4/8/2008 10:22:03 AM
TAMPA, FL--(Marketwire - April 08, 2008) - Nanobac Pharmaceuticals, Inc. (OTCBB: NNBP) ("Nanobac" or "the Company") announces an audio interview of scientists at Mayo Clinic that discusses calcifying nanoparticles (CNPs or NPs) in arterial and kidney stone disease. The researchers discuss CNPs both as a cause and accelerant of diseases. Please go to Nanobac's website or www.lifelines.tv and listen to episode 7.
comments powered by